JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Analysis of Cerebrospinal Fluid and Serum CEA Concentration in Non-neoplastic Diseases.

BACKGROUND: Carcinoembryonic antigen (CEA) in cerebrospinal fluid (CSF) is important for the diagnosis of meningeal carcinomatosis. Its relationship with CSF and serum in non-neoplastic diseases may be beneficial for earlier diagnosis and treatment.

METHODS: CSF samples were obtained from 346 non-neoplastic inpatients. Among them, 238 pairs of CSF and serum were obtained and compared. The 97.5(th) percentile and maximum value of CSF CEA were obtained.

RESULTS: The 97.5(th) percentile and maximum value of CSF CEA concentration for overall participants were 0.529 and 2.340 µg/L, respectively. The ratio of CEA level (CSF/serum) was from 0.017 to 1. CSF CEA concentration was equal to the simultaneous serum concentration only in 0.84% (2/238) and no higher than simultaneous serum CEA concentration was found.

CONCLUSIONS: The value determined in this study of CSF CEA is significantly lower than that usually used in clinical practice. CSF CEA concentration higher than the simultaneous serum CEA concentration suggests abnormal intrathecal CEA secretion.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app